Cargando…
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways
BACKGROUND: Wilms' tumour 1 (WT1) gene was discovered as a tumour suppressor gene. Later findings have suggested that WT1 also can be oncogenic. This complexity is partly explained by the fact that WT1 has a number of target genes. METHOD: WT1 and its target gene human telomerase reverse transc...
Autores principales: | Sitaram, R T, Degerman, S, Ljungberg, B, Andersson, E, Oji, Y, Sugiyama, H, Roos, G, Li, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967054/ https://www.ncbi.nlm.nih.gov/pubmed/20842112 http://dx.doi.org/10.1038/sj.bjc.6605878 |
Ejemplares similares
-
Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells
por: Ohyashiki, J H, et al.
Publicado: (2005) -
Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation
por: Klapper, W, et al.
Publicado: (2003) -
Single Nucleotide Polymorphisms in the Wilms’ Tumour Gene 1 in Clear Cell Renal Cell Carcinoma
por: Li, Xingru, et al.
Publicado: (2013) -
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
por: Lantuejoul, S, et al.
Publicado: (2004) -
Many disease-associated variants of hTERT retain high telomerase enzymatic activity
por: Zaug, Arthur J., et al.
Publicado: (2013)